Perturbation of protein tyrosine kinase signaling results in malignant transformation, as seen in ErbB2/HER2/Neu overexpression in breast cancer and the NPM-ALK fusion gene in anaplastic large cell lymphoma [87,88]. This evidence concerns the gene NPM1 and breast cancer.